Biogen Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $3.01B | $2.38B | $1.05B | $3.42B | $2.26B | $1.33B | $2.91B | $1.22B |
| Accounts Receivable | $1.34B | $1.40B | $1.66B | $1.71B | $1.55B | $1.91B | $1.88B | $1.96B |
| Inventory | $2.17B | $2.46B | $2.53B | $1.34B | $1.35B | $1.07B | $804.2M | $929.9M |
| Total Current Assets | $8.97B | $7.46B | $6.86B | $9.79B | $7.86B | $6.89B | $8.38B | $7.64B |
| Property, Plant & Equipment | $3.06B | $3.18B | $3.31B | $3.30B | $3.42B | $3.41B | $3.25B | $3.60B |
| Goodwill | $6.49B | $6.48B | $6.22B | $5.75B | $5.76B | $5.76B | $5.76B | $5.71B |
| Intangible Assets (Excl. Goodwill) | $9.18B | $9.69B | $8.36B | $1.85B | $2.22B | $3.08B | $3.53B | $3.12B |
| Total Assets | $29.44B | $28.05B | $26.84B | $24.55B | $23.88B | $24.62B | $27.23B | $25.29B |
| Liabilities | ||||||||
| Accounts Payable | $432.0M | $424.2M | $403.3M | $491.5M | $589.2M | $454.9M | $530.8M | $370.5M |
| Total Current Liabilities | $3.35B | $5.53B | $3.43B | $3.27B | $4.30B | $3.74B | $4.86B | $3.30B |
| Long-Term Debt | $6.29B | $6.30B | $6.94B | $6.28B | $6.27B | $7.43B | $4.46B | $5.94B |
| Total Liabilities | $11.18B | $11.33B | $12.05B | $11.17B | $12.92B | $13.93B | $13.90B | $12.26B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $20.55B | $19.26B | $17.63B | $16.47B | $13.91B | $13.98B | $16.46B | $16.26B |
| Total Stockholders' Equity | $18.26B | $16.72B | $14.80B | $13.40B | $10.90B | $10.70B | $13.34B | $13.04B |